Characterisation of the Novel HLA‐DRB1*10:52 Allele by Next‐Generation Sequencing and Oxford Nanopore Sequencing
HLA · 2026-08 · 108 (2)
DOI: 10.1111/tan.70921 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, online erschienen am 14.08.2026. Verfasst von Jarret Merschman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: HLA-DRB1 Chains, Alleles, Exons, High-Throughput Nucleotide Sequencing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
HLA‐DRB1*10:52 is characterised by a single nucleotide substitution in codon 133 in exon 3.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
ORCID-Profile: Jarret Merschman, Manish J Gandhi
Zitieren
APA
Merschman, J., Kreuter, J., Millard, K., Schneider, B., & Gandhi, M. J. (2026). Characterisation of the Novel HLA‐DRB1*10:52 Allele by Next‐Generation Sequencing and Oxford Nanopore Sequencing. HLA, 108(2). https://doi.org/10.1111/tan.70921
Vancouver
Merschman J, Kreuter J, Millard K, Schneider B, Gandhi MJ. Characterisation of the Novel HLA‐DRB1*10:52 Allele by Next‐Generation Sequencing and Oxford Nanopore Sequencing. HLA. 2026;108(2). doi:10.1111/tan.70921
BibTeX
@article{Merschman2026,
author = {Merschman, Jarret and Kreuter, Justin and Millard, Kevin and Schneider, Brittany and Gandhi, Manish J},
title = {Characterisation of the Novel HLA‐DRB1*10:52 Allele by Next‐Generation Sequencing and Oxford Nanopore Sequencing},
journal = {HLA},
year = {2026},
volume = {108},
number = {2},
doi = {10.1111/tan.70921}
}
EUVIMED